Genzyme Corp (GENZ)

CAPS Rating:

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

View Ticker Page (GENZ)

Results 11 - 20 of 33 : 1 2 3 4

Recs

0

Avatar pilarcity (62.89) Submitted: 1/18/08 7:43 AM : Start Price: $80.34 GENZ Score: -2.84

Thay are launching excellent products in high unmet medical need markets.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar BetterMoney77 (89.25) Submitted: 12/11/07 11:12 AM : Start Price: $73.53 GENZ Score: 16.10

Big profitability looking forward (accelerating growth)

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Pablocruz (24.96) Submitted: 3/13/08 3:28 PM : Start Price: $74.07 GENZ Score: 3.07

Short term pop to the up side, then down after fed rate cuts fade in the minds of investors.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar jchallis (29.37) Submitted: 3/23/08 3:19 PM : Start Price: $71.97 GENZ Score: 6.72

This company has a great competitive advantage -- they produce life-saving drugs for relatively rare diseases. Being low volume, they can continue to hold their niche against big players. Having been in the game for over 25 years, they can hold their...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Budsworth (47.47) Submitted: 4/05/08 5:29 AM : Start Price: $75.95 GENZ Score: 4.57

With the most recent resolution over manufacturing issues of MYOZYME enzyme replacement therapy for Pomp disease: should help gain favor with the FDA.
They will be announcing mid stage data for the drug CLOLAR at the American Society for Clinic...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar GS751 (96.22) Submitted: 4/15/08 11:29 AM : Start Price: $72.14 GENZ Score: 5.94

A large cap play that I stole from Florida Builder. Already priced as if the R &D is gonna come through. I'll be on the betting line.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar ResearchLover (86.75) Submitted: 4/23/08 3:42 PM : Start Price: $73.12 GENZ Score: 8.27

I like the chart with rising MAs, earnings just announced showing growth, and the forward PE of 20 at this price. Plus they could spin off or sell off any one of their six segments if business development at another company justifies a synergistic v...

Report this Post Replies: 0 | Reply | Permalink